3.79
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BTAI Giù?
Forum
Previsione
Bioxcel Therapeutics Inc Azioni (BTAI) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
28.57%
0.12
|
0.168 | 0.366 | 0.214 | 1.104 |
Cost Of Revenue |
664.29%
0.107
|
0.014 | 0.832 | 1.17 | 0.062 |
Gross Profit |
91.56%
0.013
|
0.154 | -0.466 | -0.956 | 1.042 |
|
54.74%
15.87
|
10.25 | 10.03 | 14.34 | 18.34 |
Benefits Costs and Expenses |
115.20%
15.97
|
7.422 | 11.22 | 15.51 | 18.40 |
Costs And Expenses |
55.57%
15.97
|
10.27 | 10.86 | 15.51 | 18.40 |
Operating Income/Loss |
56.97%
-15.85
|
-10.10 | -10.49 | -15.29 | -17.30 |
Income/Loss From Continuing Operations Before Tax |
118.53%
-15.85
|
-7.254 | -10.86 | -15.29 | -8.299 |
Income/Loss From Continuing Operations After Tax |
164.50%
-19.19
|
-7.254 | -10.86 | -13.65 | -8.299 |
|
164.50%
-19.19
|
-7.254 | -10.86 | -13.65 | -8.299 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
62.25%
7.843
|
4.834 | -35.32 | 42.39 | 40.25 |
Diluted Average Shares |
62.25%
7.843
|
4.834 | -35.32 | 42.39 | 40.25 |
Basic Earnings Per Share |
63.33%
-2.45
|
-1.50 | -22.22 | -0.32 | -0.21 |
Diluted Earnings Per Share |
63.33%
-2.45
|
-1.50 | -22.22 | -0.32 | -0.21 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):